# Immunai

**Canonical:** https://apis.io/providers/immunai/  
**Website:** https://www.immunai.com/  
**APIs profiled:** 0

Immunai is a New York-headquartered biotechnology company, founded in December 2018, that maps the human immune system at single-cell resolution and applies machine learning to drug discovery and development. Its central asset is AMICA (Annotated Multiomic Immune Cell Atlas), a cell-level immune knowledge base built from single-cell multiomics — RNA transcriptome, surface proteome, TCR/BCR repertoire and spatial transcriptomics — harmonized across thousands of public and proprietary studies covering hundreds of diseases and immune cell types, paired with an ImmunoDynamics Engine used for target discovery, preclinical evaluation and clinical trial optimization. Immunai works through partnerships with biopharmaceutical companies and research institutions rather than a self-serve product, and as of this profile it publishes no public developer portal, API documentation, machine-readable specification or SDKs. Offices are in New York, Tel Aviv, Prague and Zurich; the company acquired Dropprint Genomics (2021) and Nebion (2021).

## Kin Score — 9.9 / 100 (minimal)

Scored 2026-08-17 under rubric 0.11.0. Trend: flat (+0.0 from 9.9).

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 2.2 |
| Commercial Clarity | 10.5 |

Regulatory layer — **Health**: 18.8 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Security (1)

- **Immunai Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotechnology, Immunology, Drug Discovery, Artificial Intelligence, Machine Learning, Single-Cell Genomics, Multiomics, Clinical Trials, Life Sciences

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/immunai/). Scores are computed from the provider's own public artifacts under a published rubric.